Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiodarone infusion duration for atrial fibrillation conversion
NCT03432663Phase 4Completed
- Sponsor
- Hospital Zambrano Hellion
- Start
- Aug 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amiodarone in Atrial fibrillation (AFib), sponsored by Hospital Zambrano Hellion. Primary endpoint: Sinus rhythm conversion rate at 72 hours. Started Aug 2008; status: completed.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03432663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03432663.